Methylprednisolone and Tapazole drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Methylprednisolone (methylprednisolone) and Tapazole (methimazole). Common drug interactions include rash among females and neutropenia among males.
The phase IV clinical study analyzes what interactions people have when they take Methylprednisolone and Tapazole. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Methylprednisolone?
Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.
What is Tapazole?
Tapazole has active ingredients of methimazole. It is often used in hyperthyroidism. eHealthMe is studying from 2,477 Tapazole users. Check the latest studies of Tapazole.
15 people who take Methylprednisolone and Tapazole together, and have interactions are studied.

What are the common drug interactions of Methylprednisolone and Tapazole, by gender? *:
female:
- Rash
- Injury
- Pain
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Anxiety disorder
- Aphasia (damage to the parts of the brain that control language)
- Herpes zoster
- Hyperaemia (increase of blood flow to different tissues in the body)
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
- Hypoxia (low oxygen in tissues)
male:
- Neutropenia (an abnormally low number of neutrophils)
- White blood cell count decreased
- Colonic perforation (a hole in the colon)
- Confusional state
- Contusion (a type of hematoma of tissue in which capillaries)
- Culture urine positive
- Death
- Depression
- Dysphagia (a condition in which swallowing is difficult or painful)
- Electrocardiogram pr prolongation
What are the common drug interactions of Methylprednisolone and Tapazole, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Injury
- Pain
- Anal ulcer
- Atelectasis (partial or complete collapse of the lung)
- Blood culture positive
- Colonic perforation (a hole in the colon)
- Escherichia infection (bacterial infection by escherichia coli)
- Hepatomegaly (abnormal enlargement of the liver)
- Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
30-39:
n/a
40-49:
- Electrocardiogram pr prolongation
- Fall
- Grip strength decreased
- Haematocrit decreased
- Haemoglobin decreased
- Hypertension (high blood pressure)
- Lymphocyte count decreased
- Memory impairment
- Neutropenia (an abnormally low number of neutrophils)
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
50-59:
n/a
60+:
- Diarrhoea
- Astrocytoma (tumour of the brain that originate in a particular kind of glial-cells)
- Fibrocystic breast disease (a condition causing breast pain, cysts, and noncancerous breast lumps, affects many women)
- Gingival erosion (gum ulcer)
- Gingival swelling (gums swelling)
- Infection
- Jaw disorder (jaw disease)
- Jaw fracture
- Lymphoma (cancer that begins in immune system cells)
- Mass
What are the existing conditions these people have? *
- Urticaria Pigmentosa (skin disease that produces patches of darker skin (lesions) and very bad itching): 8 people, 53.33%
- Multiple Myeloma (cancer of the plasma cells): 8 people, 53.33%
- Hypersensitivity: 2 people, 13.33%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 6.67%
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 6.67%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 6.67%
- Keloids (overgrown scars left from skin injuries): 1 person, 6.67%
- Hepatocellular Carcinoma (liver cancer): 1 person, 6.67%
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 6.67%
- Constipation: 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Methylprednisolone and Tapazole?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Methylprednisolone (59,645 reports)
- Tapazole (2,477 reports)
Browse all drug interactions of Methylprednisolone and Tapazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Methylprednisolone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Tapazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Methylprednisolone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tapazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on methylprednisolone and methimazole (the active ingredients of Methylprednisolone and Tapazole, respectively), and Methylprednisolone and Tapazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cough and Uveitis - 18 seconds ago
- Could Ranitidine cause Broken Bone? - 32 seconds ago
- Could Actigall cause Atrial Fibrillation Aggravated? - 37 seconds ago
- Frova vs. Fioricet, side effect and effectiveness comparison - 54 seconds ago
- Drug interactions of Protonix and Prilosec Otc - a minute ago
- Could Esomeprazole Sodium cause Hypertensive Crisis? - a minute ago
- Maternal Therapy To Enhance Foetal Lung Maturity and Weight Gain Poor - a minute ago
- Acne and Hair Disorder - a minute ago
- Could Evenity cause Parkinson'S Disease? - a minute ago
- Could Tylenol cause Eye Injury? - a minute ago